News
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Partex NV Forges Collaboration with Sanofi in AI-Based Dossier Enrichment for Out-Licensing
Partex NV collaborates with Sanofi in AI-based dossier enrichment for out-licensing, enhancing Sanofi's portfolio with Partex's AI technology. CEO Gunjan Bhardwaj expresses dedication to innovative drug discovery -
COMMUNIQUÉ DE PRESSE
Amolyt Pharma, an Andera Partners’ portfolio company, announces its sale to AstraZeneca
Amolyt Pharma, a clinical-stage biopharmaceutical company specializing in therapeutic peptides, is being acquired by AstraZeneca for $1.05 billion. The transaction is expected to close in Q3 2024 -
COMMUNIQUÉ DE PRESSE
Bayer and Aignostics to collaborate on next generation precision oncology
Bayer and Aignostics partner to enhance precision oncology through AI-driven target identification and computational pathology algorithms. Collaboration aims to accelerate oncology drug research and development -
-
COMMUNIQUÉ DE PRESSE
Hapag-Lloyd AG: Supervisory Board renews appointment of Rolf Habben Jansen and extends contract of Donya-Florence Amer
Hapag-Lloyd AG's Supervisory Board renews CEO Rolf Habben Jansen's contract until 2029 and extends CIO/CHRO Donya-Florence Amer's contract until 2030. Board emphasizes strategic continuity and digital transformation -
COMMUNIQUÉ RÉGLEMENTÉ
Saint-Gobain accélère dans la chimie de la construction et accompagne le développement de technologies de pointe pour la décarbonation
Saint-Gobain's Construction Chemistry activity develops new low-carbon additives for cement and concrete, fostering partnerships with Fortera and Ecocem. Initiatives align with 'Grow & Impact' strategic plan
